
    
      The duration of each participant's active participation in the study will be approximately
      14-17 months (416-506 days)

      in addition to the 2 MedDRA terms: Polio immunisation 10054175 Hepatitis B immunisation
      10054181 Haemophilus influenzae type B immunisation 10069533 Tetanus immunisation 10054131
      Rotavirus immunisation 10076886 Pneumococcal immunisation 10069578
    
  